List of Studies ( Metabolite:LPC 29:0)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003988 | AN006569 | Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active | Cultured cells | Human | Cancer | CNRS | LC-MS |
| ST003945 | AN006486 | Lipidomics characterization of A375 and A375-VR melanoma cells treated with ranolazine and sampled longitudinally. | Cultured cells | Human | Cancer | University of Colorado Denver | LC-MS |
| ST003717 | AN006098 | Lipidomics analysis of mouse pancreatic cancer cells cultured RPMI, TIFM, or TIFM + arginine under lipid deprivation | Cultured cells | Mouse | Cancer | University of Chicago | LC-MS |
| ST003715 | AN006096 | Lipidomics analysis of mouse PDAC cell lines treated with tung oil | Cultured cells | Mouse | Cancer | University of Chicago | LC-MS |
| ST003714 | AN006095 | Lipidomics analysis of mouse PDAC cell lines treated with alpha-eleostearic acid | Cultured cells | Mouse | Cancer | University of Chicago | LC-MS |
